Multiomics investigation revealing the characteristics of HIV-1-infected cells in vivo

For eradication of HIV-1 infection, it is important to elucidate the detailed features and heterogeneity of HIV-1-infected cells in vivo. In this study, a hematopoietic stem cell-transplanted humanized mouse model infected with a gene-modified HIV-1 was used to reveal multiple characteristics of HIV-1-producing cells in vivo.

A research group at The Institute of Medical Science, The University of Tokyo (IMSUT) using HIV-1-infected cells performed “multiomics” analyses, which are technologies recently developed to comprehensively investigate the features of biological samples.

“Our findings describe multiple characteristics of HIV-1-producing cells in vivo, which could provide clues for the development of an HIV-1 cure.”, said the lead scientist, Kei Sato, Associate Professor (Principal Investigator) in the Division of Systems Virology, Department of Infectious Disease Control, IMSUT.

The results of this research were published in Cell Reports on July 14, 2020.

Study for “HIV-1 cure”

For eradication of HIV-1 infection, it is important to gain an in-depth understanding of the wide-ranging characteristics of HIV-1-infected cells in vivo.

Recently developed ‘omics’ analyses (*1) can be a powerful tool to identify the characteristics of HIV-1-infected cells. However, it should be noted that a large majority of the CD4+ T cells(*2) in infected individuals are uninfected, and therefore, the transcriptional profiles of “bulk” CD4+ T cells in vivo do not reflect those of “pure” HIV-1-producing cells.

Multiomics analysis to comprehensively reveal the features of HIV-1-infected cells in vivo

In this study, the research group used a human hematopoietic stem cell-transplanted humanized mouse model that maintains human leukopoiesis under relatively stable immunological conditions in vivo and a replication-competent reporter HIV-1, and used four recently developed techniques to investigate viral genomics and transcriptomics.

According to the research group, this study consisted of the four following analyses:

First, droplet digital PCR revealed the presence of potential reservoirs in infected humanized mice. Second, ligation mediated PCR showed the preference of HIV-1 to integrate into open chromatin regions, as suggested by the association of the epigenetic modifications of integration sites with viral production. Third, digital RNA-sequencing quantified the absolute copy number of viral transcripts in the HIV-1-producing cells in vivo and further identified the differentially expressed genes between virus-infected and uninfected cells. Finally, single-cell RNA-sequencing revealed and characterized the heterogeneity of the HIV-1-producing cells in vivo.

Associate Professor Sato emphasized “To our knowledge, this study is the first investigation to describe multiple aspects of HIV-1-producing cells and also the first comprehensive investigation of the characteristics of HIV-1-infected cells in vivo” .

###

For details of the research, please see the paper.

Research Notes

(*1) ‘omics’ analyses

A field of scientific study that aims to comprehensively characterize and quantify the feature of biological samples. The combination of multiple biological “-ome” information categories (e.g., genome and transcriptome).

(*2) CD4+ T cells

An immune cell subset that orchestrates the acquired immune response.

About the research

Hirofumi Aso#, Shumpei Nagaoka#, Eiryo Kawakami#, Jumpei Ito, Saiful Islam, Benjy Jek Yang Tan, Shinji Nakaoka, Koichi Ashizaki, Katsuyuki Shiroguchi, Yutaka Suzuki, Yorifumi Satou, Yoshio Koyanagi, Kei Sato* “Multiomics investigation revealing the characteristics of HIV-1-infected cells in vivo”Cell Reports

# Equally contributed. *Correspondence.

DOI: https://doi.org/10.1016/j.celrep.2020.107887

Funding

This study was supported in part by AMED J-PRIDE (19fm0208006h0003 to Kei Sato), KAKENHI Scientific Research B (18H02662 to Kei Sato), KAKENHI Scientific Research on Innovative Areas “Neovirology” (16H06429, 16K21723, 17H05813, 19H04826 to Kei Sato), JST CREST (to Kei Sato), JSPS KAKENHI PAGS 16H06279 (to K.Sato), AMED Research Program on HIV/AIDS 19fk0410014 (19fk0410014, 19fk0410019 to Yoshio Koyanagi and Kei Sato), and JSPS Research Fellow (PD 19J01713 to Jumpei Ito).